IL6 and osteoporosis: Studies have suggested that pro-inflammatory markers such as IL-6, IL-1, and TNF-alpha act as modulators of osteoblasts and osteoclasts, leading to up-regulation of osteoclast activation and osteoporosis (9, 39).